CELCUITY INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
CELCUITY INC. (CELC) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $756.27 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2022-05-16
- CELCUITY INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-03-31 was $756.27K, a 68.40% increase year-over-year.
- CELCUITY INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-03-31 was $449.10K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month |
|---|---|
| 2022-03-31 | $756.27K 10-Q · filed 2022-05-16 |
| 2021-03-31 | $449.10K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |